1. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, July 2018 Subject(s): Blood Component TransfusionBlood Safety -- standardsBlood TransfusionZika Virus Infection -- bloodZika Virus Infection -- transmissionBlood DonorsZika Virus Infection -- epidemiologyHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, December 2017 Subject(s): Blood DonorsDonor Selection -- standardsHepacivirusHepatitis C -- bloodHIV Infections -- bloodHIV-1RNA, Viral -- bloodBlood -- virologyBlood TransfusionDisease Transmission, Infectious -- prevention & controlNucleic Acid Amplification TechniquesPolymerase Chain ReactionHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Use of serological tests to reduce the risk of transmission of Trypanosoma cruzi infection in blood and blood components Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, December 2017 Subject(s): Blood DonorsChagas Disease -- bloodChagas Disease -- transmissionDisease Transmission, Infectious -- prevention & controlDonor SelectionSerologic TestsTrypanosoma cruziChagas Disease -- prevention & controlRisk ManagementHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
